CHD Chemicals Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

Quality Assessment: Weak Fundamentals Persist

CHD Chemicals remains burdened by a weak long-term fundamental profile. The company reported flat financial performance in the third quarter of FY25-26, with operating losses continuing to weigh on profitability. The latest quarter recorded a negative EBITDA of ₹-0.23 crore, underscoring ongoing operational challenges. Return on Equity (ROE) remains subdued at an average of 0.92%, indicating limited profitability generated per unit of shareholders’ funds.

Additionally, the company’s debt servicing capacity is strained, with a high Debt to EBITDA ratio of 6.72 times. This elevated leverage ratio signals increased financial risk and limited flexibility to manage debt obligations effectively. The majority of shareholders are non-institutional, which may reflect limited institutional confidence in the stock’s prospects.

Valuation and Market Capitalisation: Micro-Cap with Risky Valuations

CHD Chemicals is classified as a micro-cap stock, trading at ₹6.00 as of the latest close, up 2.04% on the day from ₹5.88. The stock’s 52-week price range spans ₹4.11 to ₹6.72, reflecting moderate volatility. Despite recent gains, the stock’s valuation remains risky relative to its historical averages, partly due to its negative EBITDA and weak profitability metrics.

Over the past year, the stock has generated a modest return of 4.35%, outperforming the Sensex which declined by 3.74% over the same period. Year-to-date, CHD Chemicals has delivered a 10.50% return, significantly ahead of the Sensex’s negative 9.26%. However, longer-term returns remain disappointing, with a five-year loss of 52.42% contrasting sharply with the Sensex’s 57.15% gain.

Financial Trend: Flat Performance with Persistent Losses

The company’s recent quarterly results have been largely flat, with no significant improvement in core financial metrics. Operating losses continue to erode earnings, and the negative EBITDA highlights ongoing operational inefficiencies. Profit growth over the past year has been modest at 6%, insufficient to offset the broader financial weaknesses.

CHD Chemicals’ inability to generate positive cash flows and improve profitability metrics raises concerns about its medium to long-term viability. The weak financial trend is a key factor keeping the overall rating at Sell despite technical improvements.

Technical Analysis: Shift to Mildly Bullish Signals

The primary catalyst for the upgrade from Strong Sell to Sell is the improvement in technical indicators. The technical trend has shifted from sideways to mildly bullish, signalling a potential positive momentum in the stock price.

Key technical signals include a mildly bullish Moving Average Convergence Divergence (MACD) on both weekly and monthly charts, alongside bullish Bollinger Bands on the same timeframes. The Dow Theory also supports a mildly bullish stance on weekly and monthly scales. However, some indicators remain mixed: the daily moving averages are mildly bearish, and the monthly Know Sure Thing (KST) indicator is bearish, reflecting some caution.

The Relative Strength Index (RSI) on weekly and monthly charts shows no clear signal, indicating the stock is neither overbought nor oversold. Overall, the technical picture suggests cautious optimism, with the stock showing signs of upward momentum but still facing resistance.

Price and Return Comparison with Sensex

CHD Chemicals’ recent price action has been relatively strong compared to the broader market. Over the past week, the stock surged 13.64%, vastly outperforming the Sensex’s 0.54% gain. Similarly, over the past month, the stock returned 15.83% while the Sensex declined by 0.30%. Year-to-date returns of 10.50% further highlight the stock’s relative strength amid a declining benchmark.

Despite these short-term gains, the stock’s longer-term performance remains weak. Over three years, it has returned 16.28%, lagging the Sensex’s 25.20%. The five-year and ten-year returns are deeply negative at -52.42% and -25.00% respectively, compared to the Sensex’s robust gains of 57.15% and 206.51%. This disparity underscores the company’s ongoing fundamental challenges despite recent technical improvements.

Outlook and Investor Considerations

While the technical upgrade to Sell from Strong Sell reflects a modest improvement in market sentiment and price momentum, CHD Chemicals’ fundamental weaknesses remain a significant concern. The company’s flat financial performance, negative EBITDA, and high leverage suggest ongoing operational and financial risks.

Investors should weigh the mildly bullish technical signals against the company’s weak profitability and risky valuation. The stock’s micro-cap status and majority non-institutional ownership further add to its speculative nature. Those considering exposure to CHD Chemicals should remain cautious and monitor quarterly results closely for any signs of fundamental turnaround.

In summary, the upgrade to Sell is primarily a technical-driven reassessment rather than a fundamental improvement. The company’s financial trend and quality metrics continue to warrant a cautious stance, with the Sell rating reflecting a balance between emerging positive price signals and persistent underlying risks.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →